Prophylactic hydrocortisone in extremely preterm infants and brain MRI abnormality

Autor: Alison, Marianne, Tilea, Bogdana, Toumazi, Artemis, Biran, Valérie, Mohamed, Damir, Alberti, Corinne, Bourmaud, Aurélie, Baud, Olivier, PREMILOC Trial group

Publikováno v: Archives of Disease in Childhood Fetal and Neonatal Edition (2020)
Archives of disease in childhood. Fetal and neonatal edition
Archives of disease in childhood. Fetal and neonatal edition, BMJ Publishing Group, 2020, 105 (5), pp.520-525. ⟨10.1136/archdischild-2019-317720⟩
Archives of disease in childhood.Fetal and neonatal edition
Archives of disease in childhood.Fetal and neonatal edition, BMJ Publishing Group, 2020, 105 (5), pp.520-525. ⟨10.1136/archdischild-2019-317720⟩

ObjectiveTo determine whether early low-dose hydrocortisone treatment in extremely preterm infants is associated with brain damage assessed by MRI at term equivalent of age (TEA).Patients and outcomesThis is a predefined secondary analysis of brain a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5eb6be7a7c2f966726d0e3372a5ab47
https://archive-ouverte.unige.ch/unige:137352

Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.

Autor: PREMILOC Trial Group, Trousson, Clémence, Leroy, Emilie, Baud, Olivier, Biran, Valérie, Mohamed, Damir, Alberti, Corinne

Publikováno v: JAMA: Journal of the American Medical Association; 4/4/2017, Vol. 317 Issue 13, p1329-1337, 9p, 3 Charts